Objectives Linezolid may be an effective treatment for multidrug-resistant (MDR) and
extensively drug-resistant (XDR) tuberculosis (TB). The objective was to evaluate the …

Introduction Historically, extensively drug-resistant tuberculosis has been notoriously difficult
to treat with devasting outcomes. As we are coming to the end of an era where the 2006 …

Multi drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) are
burgeoning global problems with high mortality which threaten to destabilise TB control …

Emergence of extensively drug-resistant tuberculosis (XDR-TB) has significantly threatened
to jeopardize global efforts to control TB, especially in HIV endemic regions. XDR-TB is …

The quick and accurate identification of microorganisms and the study of resistance to
antibiotics is crucial in the economic and industrial fields along with medicine. One of the …

Tuberculosis (TB) remains a global emergency and is responsible for 1.7 million deaths
annually. Widespread global misuse of isoniazid and rifampicin over three decades has …

Although molecular tests for drug-resistant TB perform well on culture isolates, their
accuracy using clinical samples, particularly from TB and HIV-endemic settings, requires …

In spite of the growing awareness of emerging drug-resistant Mycobacterium tuberculosis,
the extent of inappropriate tuberculosis (TB) case management may be underestimated …

Para-aminosalicylic acid (PAS) is one of the last remaining drugs available to treat
extensively drug-resistant (XDR) tuberculosis. Good outcomes (81% 5 year survival) were …

The global tuberculosis (TB) epidemic has been complicated by the emergence of strains of
Mycobacterium tuberculosis resistant to anti-TB drugs. Misuse of drugs to treat TB, for …